$PVCT PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROVECTUS BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PROVECTUS BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in PROVECTUS BIOPHARMACEUTICALS, INC. for free.
IRS Number: 900031917
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PVCT
Company Address: 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE 37932
Phone number: 865-769-4011
Former name: SPM GROUP INC, date of change: 1992-07-03
Former name: ZAMAGE DIGITAL IMAGING INC, date of change: 2001-11-26
Former name: PROVECTUS PHARMACEUTICALS INC, date of change: 2002-04-17
Market Capitalization: $4.61M
Prev close: $0.02
Average Daily Volume: 4,165,240
Days Low: $0.02
Year Low: $0.01
Year High: $0.54
PROVECTUS BIOPHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | PVCT | PROVECTUS BIOPHARM ... | Pershing Edward | Director | Option Exercise | M | 0.00 | 478,926 | 0 | 478,926 | |
| Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Raines Heather | CFO | Grant | A | 0.00 | 50,000 | 0 | 1,213,153 | 1.2 M to 1.2 M (+4.30 %) |
| Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Lacy John III | Director | Option Exercise | A | 0.29 | 100,000 | 28,620 | 100,000 | |
| Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Lacy John III | Director | Grant | A | 0.00 | 100,000 | 0 | 200,000 | 100 K to 200 K (+100.00 %) |
| Mar 27 2019 | PVCT | PROVECTUS BIOPHARM ... | Raines Heather | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 1,163,153 | 1.1 M to 1.2 M (+4.49 %) |
| Dec 18 2017 | PVCT | PROVECTUS BIOPHARM ... | Glass John R | See Remarks | Buy | P | 0.05 | 115,900 | 6,259 | 200,000 | 84.1 K to 200 K (+137.81 %) |
| Dec 18 2017 | PVCT | PROVECTUS BIOPHARM ... | Glass John R | See Remarks | Buy | P | 0.05 | 84,100 | 4,533 | 84,100 | 0 to 84.1 K |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 106,000 | 106,000 | 296,503 | 190.5 K to 296.5 K (+55.64 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 27,333 | 27,333 | 1,411,829 | 1.4 M to 1.4 M (+1.97 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 133,333 | 133,333 | 1,384,496 | 1.3 M to 1.4 M (+10.66 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | O | 0.85 | 306,947 | 260,905 | 306,947 |
View all PROVECTUS BIOPHARMACEUTICALS, INC. insider transactions.